stockrow
Saturday 31 October 2026
Export OHI’s income statement to Excel — free account
Omega Healthcare Investors, Inc.
OHI Real Estate Reit Healthcare Facilities
Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024. In the quarter to June 2026, revenue grew 16.2%, EPS grew 163.0%, free cash flow grew 710.6% and total debt fell 99.9%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three; insiders bought in the last twelve months.
46.98
0.14
+0.30%
Follow OHI
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
16.85 | 21.07 | 22.74 | 23.33 |
+8 more quarters Free account |
P/S ratio |
11.11 | 10.53 | 10.87 | 10.86 | |
P/FCF ratio |
17.12 | 184.85 | 159.52 | 80.73 | |
P/Operating CF |
65.45 | 60.40 | 56.07 | 55.09 | |
P/B ratio |
2.53 | 2.39 | 2.38 | 2.38 | |
Price to Tangible BV |
2.85 | 2.71 | 2.70 | 2.72 | |
EV/Sales |
10.98 | 14.08 | 11.02 | 14.53 | |
EV/EBITDA |
12.45 | 15.81 | 12.57 | 16.37 | |
EV/Operating CF |
15.80 | 19.08 | 14.93 | 19.06 | |
EV/FCF |
16.91 | 247.17 | 161.84 | 108.00 | |
Quick Ratio |
2.10 | 1.21 | 1.89 | 3.15 | |
Current Ratio |
6.03 | 5.32 | 5.81 | 7.11 | |
Net Debt/EBITDA |
(0.62) | 15.68 | 0.68 | 14.67 | |
Debt/Assets |
0.06% | 43.40% | 2.41% | 47.14% | |
Debt/Equity |
0.00 | 0.81 | 0.04 | 0.95 | |
Asset Turnover |
0.12 | 0.12 | 0.12 | 0.11 | |
Operating CF/Net income |
0.58 | 1.54 | 1.35 | 1.24 | |
Capex/Depreciation |
4.44 | (1.85) | (4.34) | (0.11) | |
Interest Coverage |
3.92 | 4.13 | 3.78 | 3.52 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.79% | 8.06% | 7.83% | 7.63% | |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
7.14% | 3.28% | 3.09% | 2.98% | |
Graham Net Nets |
(0.16) | (0.23) | (0.20) | (0.22) | |
Graham Number |
34.67 | 29.32 | 28.61 | 26.87 | |
Earnings Yield |
5.94% | 4.75% | 4.40% | 4.29% | |
Free Cash Flow Yield |
5.84% | 0.54% | 0.63% | 1.24% | |
Revenue per Share |
1.10 | 1.09 | 1.09 | 1.05 | |
Operating CF per Share |
0.73 | 0.73 | 0.79 | 0.77 | |
Capex per Share |
1.46 | (0.46) | (1.19) | (0.03) | |
Free Cash Flow per Share |
2.19 | 0.26 | (0.40) | 0.73 | |
Cash per Share |
0.62 | 0.18 | 0.19 | 2.62 | |
Shareholders Equity per Share |
18.88 | 18.36 | 18.65 | 17.73 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
18.88 | 18.36 | 18.65 | 17.73 | |
Free Cash Flow |
654.61 | 77.69 | (117.43) | 217.38 | |
Working Capital |
1,749.35 | 1,459.70 | 1,694.06 | 2,185.08 | |
Capital Expenditures |
436.89 | (137.82) | (348.05) | (9.34) | |
Net Current Asset Value |
(2,275.26) | (2,981.59) | (2,561.95) | (2,809.46) | |
EV/EBIT |
17.72 | 22.63 | 18.29 | 24.06 | |
Capex to Sales |
(1.33) | 0.43 | 1.09 | 0.03 | |
Price to Operating Income |
17.94 | 16.93 | 18.03 | 17.99 | |
| Other line items | |||||
Average Receivables |
445.58 | 349.32 | 477.99 | 349.15 | |
Average Assets |
10,280.62 | 9,970.14 | 9,973.48 | 10,083.94 | |
Average Common Equity |
5,415.65 | 5,193.52 | 5,085.67 | 4,822.18 |
Columns are period end dates · fundamentals updated 25 Oct 2026